General Information of DTT (ID: TTPF2QI)

DTT Name Caspase-3 (CASP3) DTT Info
Gene Name CASP3

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
PAC1 DMYQUIP Anaplastic astrocytoma 2A00.0 Phase 1 [1]
------------------------------------------------------------------------------------
18 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
2-(4-fluoro-benzyl)isoquinoline-1,3,4-trione DMZSHDR Discovery agent N.A. Investigative [2]
2-(4-methoxy-benzyl)isoquinoline-1,3,4-trione DMHAE31 Discovery agent N.A. Investigative [2]
2-allylisoquinoline-1,3,4-trione DM3DE9Z Discovery agent N.A. Investigative [2]
2-benzylisoquinoline-1,3,4-trione DME7SAV Discovery agent N.A. Investigative [2]
2-methylisoquinoline-1,3,4-trione DMHW9GL Discovery agent N.A. Investigative [2]
2-phenethylisoquinoline-1,3,4-trione DMPWG21 Discovery agent N.A. Investigative [2]
5-(azepan-1-ylsulfonyl)indoline-2,3-dione DMGIO3R Discovery agent N.A. Investigative [3]
5-(azetidin-1-ylsulfonyl)indoline-2,3-dione DMJIVLY Discovery agent N.A. Investigative [3]
5-(piperidin-1-ylsulfonyl)indoline-2,3-dione DMT60AM Discovery agent N.A. Investigative [3]
5-(pyrrolidin-1-ylsulfonyl)indoline-2,3-dione DMJBK7F Discovery agent N.A. Investigative [3]
Ac-Asp-Glu-Val-Asp-CHO DM4KQUS Discovery agent N.A. Investigative [4]
Ac-DEVD-CHO DMW02H7 Discovery agent N.A. Investigative [5]
AZ10417808 DMNO6PL Discovery agent N.A. Investigative [6]
Glionitrin A DM98CSW Solid tumour/cancer 2A00-2F9Z Investigative [7]
Isoquinoline-1,3,4(2H)-trione DMT4RI2 Discovery agent N.A. Investigative [2]
M826 DM9NPE4 Discovery agent N.A. Investigative [8]
PETCM DM0N1DH Discovery agent N.A. Investigative [9]
SJ-8002 DMEQBU2 Solid tumour/cancer 2A00-2F9Z Investigative [10]
------------------------------------------------------------------------------------
⏷ Show the Full List of 18 Investigative Drug(s)
Molecule Interaction Atlas

References

1 Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy. Nat Chem Biol. 2006 Oct;2(10):543-50.
2 Design, synthesis, and biological evaluation of isoquinoline-1,3,4-trione derivatives as potent caspase-3 inhibitors. J Med Chem. 2006 Mar 9;49(5):1613-23.
3 Design, synthesis, and discovery of novel non-peptide inhibitor of Caspase-3 using ligand based and structure based virtual screening approach. Bioorg Med Chem. 2009 Aug 15;17(16):6040-7.
4 Design and synthesis of a potent and selective peptidomimetic inhibitor of caspase-3. J Med Chem. 2004 Dec 16;47(26):6455-8.
5 Synthesis and evaluation of vinyl sulfones as caspase-3 inhibitors. A structure-activity study. Eur J Med Chem. 2010 Sep;45(9):3858-63.
6 Novel small molecule inhibitors of caspase-3 block cellular and biochemical features of apoptosis. J Pharmacol Exp Ther. 2003 Jan;304(1):433-40.
7 Glionitrin A, a new diketopiperazine disulfide, activates ATM-ATR-Chk1/2 via 53BP1 phosphorylation in DU145 cells and shows antitumor effect in xenograft model. Biol Pharm Bull. 2014;37(3):378-86.
8 Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitors. Bioorg Med Chem Lett. 2005 Feb 15;15(4):1173-80.
9 Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science. 2003 Jan 10;299(5604):223-6.
10 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1619).